Fundraising Fox
Michael Gilman
InvestorDr. at Novartis Venture Fund
Find your path to Michael
Sign up to see every warm intro you have to Michael
- Paths you didn't know you had: your email and LinkedIn already hold routes to Michael. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Michael Gilman, PhD, is a scientist, general manager, biotech executive and entrepreneur. He founded and led Padlock Therapeutics (acquired by Bristol-Myers Squibb in 2016) and Stromedix (acquired by Biogen Idec), and held senior research and pipeline roles at Biogen Idec and ARIAD Pharmaceuticals. Earlier he was on the scientific staff at Cold Spring Harbor Laboratory; he holds a PhD in Biochemistry from UC Berkeley and an SB in Life Science from MIT.
Invests in
Biotech
Investments
Board seats
Arrakis TherapeuticsObsidian TherapeuticsScholar RockX4 Pharmaceuticals
Per the firm's website.
Colleagues at Novartis Venture Fund
Frequently asked questions
- Who is Michael Gilman?
- Michael Gilman, PhD, is a scientist, general manager, biotech executive and entrepreneur. He founded and led Padlock Therapeutics (acquired by Bristol-Myers Squibb in 2016) and Stromedix (acquired by Biogen Idec), and held senior research and pipeline roles at Biogen Idec and ARIAD Pharmaceuticals. Earlier he was on the scientific staff at Cold Spring Harbor Laboratory; he holds a PhD in Biochemistry from UC Berkeley and an SB in Life Science from MIT.
- Where does Michael Gilman work?
- Michael Gilman is Dr. at Novartis Venture Fund.
- What does Michael Gilman invest in?
- Michael Gilman invests in Biotech.
- What boards does Michael Gilman sit on?
- Michael Gilman holds tracked board seats at Arrakis Therapeutics, Obsidian Therapeutics, Scholar Rock, X4 Pharmaceuticals.
About this profile. Compiled from public sources — Novartis Venture Fund's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights